Caxton Associates (New York)’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-11,087
| Closed | -$747K | – | 563 |
|
|
2020
Q1 | $747K | Buy |
11,087
+7,543
| +213% | +$508K | 0.14% | 88 |
|
|
2019
Q4 | $299K | Buy |
+3,544
| New | +$299K | 0.04% | 271 |
|
|
2019
Q3 | – | Sell |
-5,064
| Closed | -$320K | – | 490 |
|
|
2019
Q2 | $320K | Sell |
5,064
-736
| -13% | -$46.5K | 0.04% | 257 |
|
|
2019
Q1 | $279K | Buy |
+5,800
| New | +$279K | 0.04% | 268 |
|